International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Global Aerosol Delivery Devices Market Research Report 2023-2028:
According to the latest report by IMARC Group, titled " Aerosol Delivery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and For ecast 2023-2028
," the global aerosol delivery devices market size reached US$ 44.4 Billion in 2022.
Aerosol delivery devices refer to an advanced method of drug administration wherein a drug is directly delivered to the lungs for a systemic effect. Some commonly used aerosol delivery devices include pressurized metered-dose inhalers, nebulizers, and valved holder chambers. They are generally used as rescue therapy or permanent treatment for various respiratory disorders, such as asthma, obstructive lung diseases, cystic fibrosis (CF), pulmonary arterial hypertension, and infectious pulmonary. They are also utilized in treating non-respiratory conditions, including diabetes, analgesia, thyroid disorders, and genetic diseases. They aid in lowering the dosage requirements, minimizing systemic adverse effects, and improving the ability of patients to self-administer medications. As a result, aerosol delivery devices find extensive applications in drug delivery and treatment of various medical conditions.
Request for a PDF sample of this report:
https://www.imarcgroup.com/aerosol-delivery-devices-market/requestsample
The rising incidences of chronic respiratory diseases due to surging air pollution levels, allergens, occupational risks, and unhealthy habits like smoking represent the primary factor driving the market growth. Moreover, the sudden coronavirus disease (COVID-19) outbreak that causes acute respiratory infections among patients is another major growth-inducing factor. In addition, there has been widespread adoption of aerosol delivery devices in treating obstructive airway diseases at home and in healthcare settings. Along with this, the expanding geriatric population that is more susceptible to developing critical health conditions has augmented the product demand. Besides this, the increasing preferences for personalized drug therapy coupled with the advent of novel macromolecular medications have propelled market growth.
Furthermore, the leading manufacturers are introducing innovative product variants that assist in treating chronic inflammation and infection in the lungs and improve airway clearance in patients with CF. In line with this, the development of convenient, economical, and portable inhalation devices has accelerated product adoption rates. Apart from this, the rising usage of e-commerce channels for purchasing medical supplies and the availability of mini ultrasonic nebulizers and inhalers that have automatic memory and are easy to use while traveling are providing a positive thrust to the market growth.
Looking forward, IMARC Group expects the market to reach US$ 63.3 Billion by 2028, exhibiting at a CAGR of 5.4% during 2023-2028.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/aerosol-delivery-devices-market
Key Market Segmentation
The research report includes the following segments:
Breakup by Product:
• Dry Powder Inhalers
• Single Dose Inhalers
• Multi Dose Inhalers
• Metered Dose Inhalers
• Conventional Pressurized Inhalers
• Soft Mist Inhalers
• Nebulizers
• Jet Nebulizers
• Ultrasonic Wave Nebulizers
• Vibrating Mesh Nebulizers
Breakup by Application:
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Cystic Fibrosis
• Non-Respiratory Diseases
• Diabetes
• Analgesia
• Parkinson’s Disease
Breakup by Distribution Channel:
• Retail Pharmacies
• Hospital Pharmacies
• Online Stores
Breakup by Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
Competitive Landscape with Key Players:
• 3M Company
• Aerogen
• GlaxoSmithKline plc
• Johnson & Johnson
• Koninklijke Philips N.V
• Merck & Co. Inc
• Metall Zug AG
• Recipharm AB (publ)
• Teva Pharmaceutical Industries Ltd
• Vectura Group plc
1. What was the size of the global aerosol delivery devices market in 2022?
2. What is the expected growth rate of the global aerosol delivery devices market during 20232028?
3. What are the key factors driving the global aerosol delivery devices market?
4. What has been the impact of COVID-19 on the global aerosol delivery devices market?
5. What is the breakup of the global aerosol delivery devices market based on the product?
6. What is the breakup of the global aerosol delivery devices market based on the distribution channel?
7. What are the key regions in the global aerosol delivery devices market?
8. Who are the key players/companies in the global aerosol delivery devices market?
6 Market Breakup by Product
6.1 Dry Powder Inhalers
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Single Dose Inhalers
6.1.2.2 Multi Dose Inhalers
6.2 Metered Dose Inhalers
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Conventional Pressurized Inhalers
6.2.2.2 Soft Mist Inhalers
6.2.3 Market Forecast
6.3 Nebulizers
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Jet Nebulizers
6.3.2.2 Ultrasonic Wave Nebulizers
Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/aerosol-delivery-devices-market/toc
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
